Platinum Bio Labs · Research Library
Clear answers.
Strong sources.
Start with the compound you’re interested in. Each guide covers what it is, why it appears in research, and where the evidence stops.
01Bacteriostatic Water: A Laboratory-Supply Primer
What bacteriostatic water is, how it differs from sterile water, and why compatibility must never be assumed.
Read primer →
02PT-141 / Bremelanotide: A Melanocortin Primer
PT-141's melanocortin-receptor context and the distinction between a chemical reference and an approved prescription product.
Read primer →
03Tesamorelin: A GHRH-Analog Research Primer
Tesamorelin's growth-hormone-releasing-hormone activity and the boundary between research material and approved medicine.
Read primer →
04Epithalon: A Tetrapeptide and Telomere-Model Primer
Epithalon's AEDG sequence and what cell-culture telomerase findings do—and do not—establish.
Read primer →
05SS-31 / Elamipretide: A Cardiolipin Research Primer
How SS-31 is studied at mitochondrial membranes and why an approved drug does not validate a third-party research vial.
Read primer →
06KPV: An Alpha-MSH-Derived Tripeptide Primer
KPV structure, epithelial signaling research, and the preclinical limits of current evidence.
Read primer →
07SLU-PP-322: A Catalog Identity Verification Note
The catalog says SLU-PP-322, while the published ERR agonist is SLU-PP-332—a mismatch that must be resolved.
Read primer →
08Melanotan Ace: Resolve Identity Before Mechanism
Why the exact sequence behind Melanotan Ace must be confirmed before assigning melanocortin research claims.
Read primer →
09Ipamorelin: A Growth-Hormone-Secretagogue Primer
Ipamorelin's receptor pharmacology and the preclinical basis of its research classification.
Read primer →
10HGH 191AA: A Somatropin Identity Primer
What 191AA signifies and why a research vial is not equivalent to an approved somatropin medicine.
Read primer →
11CJC-1295 No DAC + Ipamorelin: A Two-Signal Research Primer
The separate signaling rationales behind a CJC-1295 No DAC and Ipamorelin catalog blend.
Read primer →
12CJC-1295 No DAC: A GHRH-Analog Identity Primer
Why CJC-1295 with DAC and materials sold as No DAC must be distinguished analytically.
Read primer →
13Selank: A Tuftsin-Analog Research Primer
How Selank is classified and what early gene-expression studies can—and cannot—tell us.
Read primer →
14Semax: An ACTH-Fragment Analog Research Primer
Semax structure, neurotrophin-focused animal research, and the limits of translation.
Read primer →
15Vitamin B12: A Cobalamin Cofactor Primer
B12 chemistry, its two human cofactor systems, and the need to identify the exact cobalamin form.
Read primer →
16NAD+: A Cellular Redox Cofactor Primer
Why NAD+ is central to redox chemistry, and why it is not a peptide.
Read primer →
17Tirzepatide: A Dual-Incretin Research Primer
Tirzepatide's GIP and GLP-1 receptor activity, plus the crucial distinction between a research material and an approved medicine.
Read primer →
18GHK-Cu: A Copper-Tripeptide Research Primer
The chemistry of GHK-Cu and the cell-culture evidence behind its extracellular-matrix research context.
Read primer →
19MOTS-c: A Mitochondrial-Derived Peptide Primer
How MOTS-c links mitochondrial genetics, AMPK signaling, and preclinical metabolic research.
Read primer →
20Wolverine Blend: Understanding BPC-157 and TB-500
Why BPC-157 and TB-500 are grouped, and why a catalog pairing is not evidence of synergy.
Read primer →
21TB-500 and Thymosin Beta-4: Naming Matters
A careful look at TB-500 nomenclature, thymosin beta-4 research, and why the terms are not interchangeable.
Read primer →
22BPC-157: A Preclinical Research Primer
What BPC-157 is, why it appears in tissue-model research, and where the evidence stops.
Read primer →
23Retatrutide: A Triple-Receptor Research Primer
A neutral introduction to retatrutide, its three receptor targets, and the limits of current evidence.
Read primer →